Newborn Screening (NBS) Data, Michigan, 2013–2017

The Bloodline Sickle Cell Data Collection Program Quarterly Newsletter

The Bloodline is a quarterly newsletter that provides updates about the SCDC program. Click here to read past newsletters, and subscribe to the newsletter to stay updated on the SCDC program’s health communications activities, data, presentations, and more.

The Sickle Cell Data Collection (SCDC) program monitors and reports on the health of people with sickle cell disease (SCD) over time. Data from the state’s newborn screening (NBS) program are an important part of the SCDC program because they provide information about the SCD births that occur every year. Michigan’s most recent NBS data, 2013–2017, are presented below.

The data provide the number of babies born with SCD in the state, their demographics, and their type of SCD. The people included in these data were born in Michigan during 2013–2017 and reported by the state NBS program with a confirmed diagnosis of SCD.

The individuals in the NBS data are also included in the Michigan SCDC program data for the years during which they were living in the state.

Map 1: Number of SCD births by county of birth, Michigan Newborn Screening Data, 2013–2017
Map 1: Number of SCD births by county of birth, Michigan Newborn Screening Data, 2013–2017

Map 1: About 22% of the counties in Michigan had at least one SCD birth during 2013–2017. More than 40% of the SCD births in Michigan occurred in Wayne County.

Figure 1: Annual Number of SCD Births, Michigan Newborn Screening Data, 2017
Figure 1: Annual Number of SCD Births, Michigan Newborn Screening Data, 2017

Figure 1. There were 64 SCD births in Michigan during 2017.

Figure 2: Sex, Michigan Newborn Screening Data, 2013–2017
Figure 2: Sex, Michigan Newborn Screening Data, 2013–2017

Figure 2: There were a total of 294 SCD births in Michigan during 2013–2017. There were 144 male births (49%) and 150 female births (51%).

*NOTE: The sum of all categories may be less than the total number of births if there are individuals with missing data.

Figure 3: Confirmed Type of SCD, Michigan Newborn Screening Data, 2013–2017
Figure 3: Confirmed Type of SCD, Michigan Newborn Screening Data, 2013–2017

Figure 3: Fifty-five percent of the SCD births in Michigan during 2013–2017 were babies with hemoglobin (Hb) S/S or S/β0 thalassemia, 34% were Hb S/C, and 10% were Hb S/β+ thalassemia. The remaining babies had other or unknown types of SCD.

*NOTE: The sum of all categories may not total to 100% due to rounding errors.